- Email: [email protected]
Exam 2: Incidence, Outcomes, and Health Services Burden of Very Early Onset Inflammatory Bowel Disease
e14
CME Activities
Gastroenterology Vol. 147, No. 4
Question 3: On a population basis, the proportion of UGIB owing to concomitant drug use is reflected in the populationattributable risk (PAR). This number also provides information on the magnitude of potential preventable UGIBs in the general population when appropriate and correct use of gastroprotective drugs is applied. When is the PAR highest?
a. If the drug is rarely used in the population and for drug-related UGIB is high. b. If the drug is frequently used in the population risk for drug-related UGIB is low. c. If the drug is rarely used in the population and for drug-related UGIB is low. d. If the drug is frequently used in the population risk for drug-related UGIB is high.
the risk and the the risk and the
Question 4: A 66-year-old woman with hypertension, for which she uses a b-blocker and aldosterone antagonist, underwent a screening colonoscopy. During consultation, she asks your advice for another problem. She suffers from mild annoying pain in her knee. What do you recommend her to take as appropriate pain relief therapy?
a. Any NSAID. b. COX-2 inhibitor. c. Any NSAID plus a gastroprotective agent (being a proton pump inhibitor, misoprostol, or double-dosed histamine-2 receptor antagonist). d. COX-2 inhibitor plus a gastroprotective agent (being a proton pump inhibitor, misoprostol, or double-dosed histamine-2 receptor antagonist).
Exam 2: Incidence, Outcomes, and Health Services Burden of Very Early Onset Inflammatory Bowel Disease Test ID No.: gastro00211
Contact hours: 1.0
Expiration Date: October 31, 2015
Question 1: In which age group was the incidence of IBD increasing most rapidly?
a. b. c. d. e.
<6 years. 6e9.9 years. 10 years. <18 years. a and b have equally increasing incidence.
Question 2: In the 2 years before the diagnosis of IBD, which of the following statements is true?
a. Children <6 years were less likely to be diagnosed with rectal bleeding, diarrhea, or arthralgias compared with patients 10 years. b. Children <6 years were more likely to be diagnosed with rectal bleeding, diarrhea, or arthralgias compared with patients 10 years. c. Children <6 years were more likely to be diagnosed with rectal bleeding and diarrhea, but less likely to be diagnosed with arthralgias compared with patients diagnosed at 10 years. d. Irritable bowel syndrome and constipation were more common diagnoses in children 10 years compared with those <6 years. e. None of the above.
October 2014
CME Activities
e15
Question 3: Compared with children 10 years at diagnosis, which of the following statements is true?
a. Children diagnosed 6e9.9 years had lower health services utilization and surgical rates. b. Children diagnosed <6 years had lower health services utilization and surgical rates. c. Children diagnosed <6 years had higher health services utilization but not surgical rates. d. Children diagnosed <6 years and 6e9.9 years had similar health services utilization and surgical rates. e. a and b.
Question 4: Which of the following is true about the relationship between sex and age at diagnosis for health services utilization in children with IBD?
a. The differential in IBD outcomes between children diagnosed <6 years and children diagnosed 10 years is greater in males. b. The differential in IBD outcomes between children diagnosed <6 years and children diagnosed 10 years is greater in females. c. Sex does not interact with age group when determining outcomes.
Exam 3: Increased Risk of Colorectal Neoplasia Among Family Members of Patients With Colorectal Cancer: A Population-Based Study in Utah Test ID No.: gastro00212
Contact hours: 1.0
Expiration Date: October 31, 2015
Question 1: A colleague in family practice has recently read about hereditary CRC syndromes such as familial adenomatous polyposis and Lynch syndrome, which confer a markedly increased lifetime risk of CRC. He wonders if a patient who has a simple family history of CRC (not an established genetic syndrome) is also at increased risk of colorectal neoplasia. What is the best response at this point?
a. CRC does not have a familial risk outside of the known monogenic hereditary syndromes. b. CRC is caused solely be environmental exposure and does not have a genetic basis. c. Having a family history of CRC increases the risk of colorectal neoplasia (CRC and adenomas) in both close and distant relatives. This is referred to as common familial CRC. d. Only a family history of early-onset CRC increases the risk of colorectal neoplasia in relatives. e. Lynch syndrome is not associated with an elevated risk of CRC.
CME Activities
Gastroenterology Vol. 147, No. 4
Question 3: On a population basis, the proportion of UGIB owing to concomitant drug use is reflected in the populationattributable risk (PAR). This number also provides information on the magnitude of potential preventable UGIBs in the general population when appropriate and correct use of gastroprotective drugs is applied. When is the PAR highest?
a. If the drug is rarely used in the population and for drug-related UGIB is high. b. If the drug is frequently used in the population risk for drug-related UGIB is low. c. If the drug is rarely used in the population and for drug-related UGIB is low. d. If the drug is frequently used in the population risk for drug-related UGIB is high.
the risk and the the risk and the
Question 4: A 66-year-old woman with hypertension, for which she uses a b-blocker and aldosterone antagonist, underwent a screening colonoscopy. During consultation, she asks your advice for another problem. She suffers from mild annoying pain in her knee. What do you recommend her to take as appropriate pain relief therapy?
a. Any NSAID. b. COX-2 inhibitor. c. Any NSAID plus a gastroprotective agent (being a proton pump inhibitor, misoprostol, or double-dosed histamine-2 receptor antagonist). d. COX-2 inhibitor plus a gastroprotective agent (being a proton pump inhibitor, misoprostol, or double-dosed histamine-2 receptor antagonist).
Exam 2: Incidence, Outcomes, and Health Services Burden of Very Early Onset Inflammatory Bowel Disease Test ID No.: gastro00211
Contact hours: 1.0
Expiration Date: October 31, 2015
Question 1: In which age group was the incidence of IBD increasing most rapidly?
a. b. c. d. e.
<6 years. 6e9.9 years. 10 years. <18 years. a and b have equally increasing incidence.
Question 2: In the 2 years before the diagnosis of IBD, which of the following statements is true?
a. Children <6 years were less likely to be diagnosed with rectal bleeding, diarrhea, or arthralgias compared with patients 10 years. b. Children <6 years were more likely to be diagnosed with rectal bleeding, diarrhea, or arthralgias compared with patients 10 years. c. Children <6 years were more likely to be diagnosed with rectal bleeding and diarrhea, but less likely to be diagnosed with arthralgias compared with patients diagnosed at 10 years. d. Irritable bowel syndrome and constipation were more common diagnoses in children 10 years compared with those <6 years. e. None of the above.
October 2014
CME Activities
e15
Question 3: Compared with children 10 years at diagnosis, which of the following statements is true?
a. Children diagnosed 6e9.9 years had lower health services utilization and surgical rates. b. Children diagnosed <6 years had lower health services utilization and surgical rates. c. Children diagnosed <6 years had higher health services utilization but not surgical rates. d. Children diagnosed <6 years and 6e9.9 years had similar health services utilization and surgical rates. e. a and b.
Question 4: Which of the following is true about the relationship between sex and age at diagnosis for health services utilization in children with IBD?
a. The differential in IBD outcomes between children diagnosed <6 years and children diagnosed 10 years is greater in males. b. The differential in IBD outcomes between children diagnosed <6 years and children diagnosed 10 years is greater in females. c. Sex does not interact with age group when determining outcomes.
Exam 3: Increased Risk of Colorectal Neoplasia Among Family Members of Patients With Colorectal Cancer: A Population-Based Study in Utah Test ID No.: gastro00212
Contact hours: 1.0
Expiration Date: October 31, 2015
Question 1: A colleague in family practice has recently read about hereditary CRC syndromes such as familial adenomatous polyposis and Lynch syndrome, which confer a markedly increased lifetime risk of CRC. He wonders if a patient who has a simple family history of CRC (not an established genetic syndrome) is also at increased risk of colorectal neoplasia. What is the best response at this point?
a. CRC does not have a familial risk outside of the known monogenic hereditary syndromes. b. CRC is caused solely be environmental exposure and does not have a genetic basis. c. Having a family history of CRC increases the risk of colorectal neoplasia (CRC and adenomas) in both close and distant relatives. This is referred to as common familial CRC. d. Only a family history of early-onset CRC increases the risk of colorectal neoplasia in relatives. e. Lynch syndrome is not associated with an elevated risk of CRC.